securities fraud

Ardent Health shares plunged 33% after revealing a $43 million revenue adjustment due to overstated receivables. A securities fraud lawsuit was filed over misleading accounting disclosures.

CoreWeave stock dropped 16% due to data center construction delays and a failed merger. A class action lawsuit was filed over misleading guidance.

NuScale Power shares fell 12% after revealing its $495M ENTRA1 partner was misrepresented—a three-person startup, not experienced firm. Securities fraud lawsuit filed.

PennyMac Financial faces securities investigation for allegedly misleading investors about servicing segment performance. Stock plummeted 33% after fourth quarter earnings decline.

Corcept Therapeutics faces class action lawsuit over alleged misrepresentation regarding relacorilant drug. FDA rejected the application citing insufficient efficacy data; stock plummeted over 50%.

Rosen Law Firm investigates Lufax for potential securities violations after the fintech company removed auditors and delayed its annual report, causing stock to plunge 13.8%.

Class action lawsuit filed against REGENXBIO for allegedly making false statements about gene therapy safety and efficacy while withholding adverse trial information from investors.

NuScale Power faces class action lawsuit alleging false statements about partner ENTRA1's qualifications. Stock declined 12% after disclosing $495M payment and $532M quarterly loss.

Kirby McInerney LLP filed securities fraud lawsuit against Kyndryl Holdings for alleged financial misstatements and inadequate internal controls. Stock plummeted 55% after SEC scrutiny.

Hub Group restated 2025 financials after discovering material accounting errors in transportation costs and payables. Stock fell 18.3%, triggering shareholder lawsuits over disclosure adequacy.

PayPal faces class action lawsuit alleging misleading statements about Branded Checkout growth. Stock fell 20% in February 2026 following disappointing earnings and CEO change.

Law firm files class actions against Bath & Body Works and BellRing Brands for allegedly failing to disclose material information about business challenges, resulting in significant investor losses.

OST investors have until April 17, 2026 to seek lead plaintiff status in a $110M fraud case involving alleged stock price manipulation by company executives.

Enphase Energy faces securities fraud lawsuit alleging false statements about inventory management and credit exposure preparedness, affecting investors from April-October 2025.

REGENXBIO faces securities fraud lawsuit over alleged misrepresentations about RGX-111's safety and efficacy. A CNS tumor discovery contradicted prior investor statements, causing shareholder losses.

Schall Law Firm filed a securities class action against Kyndryl for allegedly making false financial disclosures and failing to maintain proper internal controls between August 2024 and February 2026.

Securities fraud lawsuit filed against uniQure for allegedly making false statements about FDA approval processes and BLA submission timelines, causing investor losses.

PayPal faces class action lawsuit alleging false statements about Branded Checkout growth prospects. Investors who purchased securities Feb 2025-Feb 2026 invited to join litigation.

Schall Law Firm sues Paysafe Limited for securities fraud, alleging false statements about merchant risk exposure and understated credit losses between March-November 2025.

Class action lawsuit filed against NuScale Power for allegedly misrepresenting nuclear partner ENTRA1's experience. Investors claim material misstatements about partner's qualifications were not disclosed timely.